Physician profile
Jonathan Cope Smith
NPI 1164461653
$4,148.63
in general payments reported to CMS, 2019-2025
27 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $255 · 2021: $567 · 2022: $580 · 2023: $819 · 2024: $766 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,278.70 | 2019-2025 | |
| Optinose US, INC. | $664.43 | 2019-2025 | |
| Glaxosmithkline, LLC. | $640.86 | 2020-2025 | Nucala |
| Astrazeneca Pharmaceuticals Lp | $320.56 | 2019-2024 | Fasenra |
| Kaleo, INC. | $226.02 | 2019-2024 | Auvi-Q |
| Medtronic, INC. | $160.00 | 2023-2025 | Propel, Sinuva |
| Stryker Corporation | $115.84 | 2019-2022 | |
| Medtronic USA, INC. | $87.01 | 2019-2020 | |
| Acclarent, INC | $82.01 | 2020-2024 | Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $80.97 | 2019 | |
| Amgen INC. | $64.79 | 2022-2025 | Tezspire |
| Inspire Medical Systems, INC. | $54.03 | 2023 | Inspire |
| Grifols USA, LLC | $48.06 | 2024 | Xembify |
| Alk-Abello, INC | $44.80 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $32.29 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $30.56 | 2025 | Checkpoint Stimulators |
| Csl Behring | $29.13 | 2019-2020 | |
| Abbvie INC. | $28.20 | 2022 | |
| Davol INC. | $28.07 | 2025 | Venovo |
| Hologic Sales and Service, LLC | $24.05 | 2024 | Coolseal Generator |
| Takeda Pharmaceuticals U.S.A., INC. | $20.61 | 2025 | Cuvitru |
| Paratek Pharmaceuticals, INC. | $17.80 | 2025 | Xhance |
| Phadia US INC. | $16.74 | 2019 | |
| Incyte Corporation | $15.25 | 2022 | |
| Pfizer INC. | $13.85 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.06 | 2019 | |
| Hikma Pharmaceuticals USA | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.